Position in LLY
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$6,298,207
+$1,398,593 QoQ
Shares Held
5,251
-1.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.98%
of 13F equity value
Holder Rank
#1,539
of 4,605 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hilltop National Bank holds $16,551,650 across 14 Drug Manufacturers - General names. LLY ranks #1 (38.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
5,251 | $6,298,207 | |
| 2 | JNJ |
Johnson & Johnson
|
12,398 | $3,148,720 | |
| 3 | AZN |
Astrazeneca PLC
|
7,577 | $1,436,749 | |
| 4 | MRK |
Merck & Co., Inc.
|
10,944 | $1,406,303 | |
| 5 | ABBV |
AbbVie Inc.
|
4,897 | $1,232,280 | |
| 6 | AMGN |
Amgen Inc
|
2,860 | $1,035,662 | |
| 7 | PFE |
Pfizer Inc
|
22,328 | $537,657 | |
| 8 | SNY |
Sanofi
|
9,572 | $408,341 |
All Filings in LLY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,298,207 | 5,251 | Shares | Defined | 2026-07-02 | |
| 2026-03-31 | $4,899,614 | 5,327 | Shares | Defined | 2026-04-02 | |
| 2025-12-31 | $5,711,923 | 5,315 | Shares | Defined | 2026-01-07 | |
| 2025-09-30 | $4,104,940 | 5,380 | Shares | Defined | 2025-10-08 | |
| 2025-06-30 | $4,452,675 | 5,712 | Shares | Defined | 2025-07-21 | |
| 2024-12-31 | $4,141,008 | 5,364 | Shares | Defined | 2025-01-10 | |
| 2024-09-30 | $4,826,600 | 5,448 | Shares | Defined | 2024-10-15 | |
| 2024-06-30 | $4,970,535 | 5,490 | Shares | Defined | 2024-07-10 | |
| 2024-03-31 | $4,212,652 | 5,415 | Shares | Defined | 2024-05-06 | |
| No filing history on record for this holder in this stock. | ||||||